MDLZ — Mondelez International
Price when we picked it (Aug 31, 2026)
$62.24
Target: $69.13 (+11.1%)
P/E Ratio
22.8
P/E Forward
18.5
Dividend
3.3%
Market Cap
$79.8B
EPS
$2.73
Consensus
Buy
What they do
Mondelez International (Chicago; ~91,000 employees; CEO Dirk Van de Put) was born in 2012 when Kraft Foods split in two: the North American grocery business stayed as Kraft and the global snacks business was renamed Mondelez. Today it sells in more than 150 countries with 145 factories in 49 countries.
Its brands: Oreo, Cadbury, Milka, Toblerone, Ritz, belVita, Chips Ahoy!, Halls, Tate's Bake Shop, Clif, Sour Patch Kids, LU, TUC, Triscuit, Wheat Thins, Côte d'Or, Philadelphia, Tang, Lacta, Marabou and 5 Star, among others. 2025 sales of $38.54 billion: biscuits 47.7%, chocolate 32.9%, gum and candy 10.5%, cheese and grocery 6.2%, beverages 2.6%. By region: Europe 39%, North America 27.7%, Asia-Middle East-Africa 20.6%, Latin America 12.7%.
2026: new CFO Amit Banati since July (Luca Zaramella moved to COO); a new Toblerone line in Bern; a $9 billion buyback authorized through 2027. On September 9 it presents at Barclays' global consumer conference.
Why we like it
Three reasons for the third buy.
- THE THESIS KEEPS DELIVERING: two straight quarters better than expected — the second quarter brought in $9.355 billion (+4.1%) with adjusted earnings of $0.73 per share vs $0.67 expected — and 2026 guidance rose to organic growth 'of at least 2%'.
- WE'RE AVERAGING WITH DISCIPLINE: April $57.03, August $62.99, today $62.24 — the third entry comes slightly CHEAPER than the second, with the same freshly raised dividend (4% to $0.52 quarterly; 3.3% a year, over a decade of increases) and 18.5x expected earnings.
- COCOA, HONESTLY: it rebounded to ~$6,500/ton this week (+25% in the month) on 2026/27 African harvest fears — but it's still ~48% below the December 2024 peak, the old expensive hedges keep expiring, and the company maintains 2027 is protected from the volatility via productivity and less cocoa-intensive products. Buy consensus with a ~$69 target (+11%).
Key Risk
#1 is still cocoa — and this week it moved against us: up ~25% in a month to ~$6,500/ton (StoneX cut its 2026/27 surplus estimate from 149,000 to ~25,000 tonnes; Ghana might harvest 450,000–550,000 tonnes vs ~750,000; Ivory Coast ~−18%). If the rebound holds, the margin takes longer to recover — in 2025 adjusted earnings fell 13% because of this. Others:
- the consumer is squeezed: confidence near lows and store brands at record share in the US;
- Europe is selling less (−3.5% organic in the quarter; they expect positive in the second half);
- GLP-1: up to 1.5% less volume by 2035 per the company itself;
- $21.2 billion of debt;
- a third buy in 5 months: MDLZ now weighs 3 positions in the portfolio — deliberate concentration, but concentration.
This is educational and informational content, not financial advice. Always consult a qualified financial advisor before making investment decisions.
Vectorial Data picked MDLZ on Apr 2, 2026 at $57.03.
Full Research
Mondelez International (MDLZ) — Complete Research
Price at first purchase (April 2, 2026): $57.03 | P/E Forward: 16.9 | Div Yield: 3.5% | Market Cap: $73.6B — see the August 2026 update at the end
What is Mondelez?
Mondelez International is one of the largest snack companies in the world, created in 2012 as a spin-off from Kraft Foods. It operates in 150+ countries with ~$36B in annual revenue and some of the most iconic snack brands on the planet.
Brands and Products
| Brand | Category | Position |
|---|---|---|
| Oreo | Cookies | #1 worldwide, sold in 100+ countries |
| Cadbury | Chocolate | Iconic in UK, India, Australia |
| Milka | Chocolate | Leader in continental Europe |
| Toblerone | Premium chocolate | Global recognition (Swiss heritage) |
| Philadelphia | Cream cheese | Global leader in its category |
| Trident | Gum | Top 3 globally |
| Tang | Powdered drink | Dominant in LATAM and Asia |
| Ritz | Crackers | Iconic in the US |
| belVita | Breakfast biscuits | Category they created |
| Halls | Lozenges | Global leader in throat lozenges |
Key Numbers 2025
| Metric | Value |
|---|---|
| Revenue | ~$36B |
| Operating Margin | ~17% (target 18-19%) |
| Free Cash Flow | ~$4B |
| Revenue outside US | ~75% |
| Employees | ~91,000 |
| Countries | 150+ |
Dividend — 10+ Years of Growth
- Annual Dividend: $2.00/share ($0.50 quarterly)
- Yield: 3.5%
- Payout Ratio: ~55% (sustainable)
- Growth: 10+ consecutive years of increase
Why MDLZ at These Prices
MDLZ trades at $57, 20% below its 52-week high ($71.15). The concerns:
- Skyrocketing cocoa costs (tripled in 2024-2025)
- Currency pressure from a strong dollar
- Conservative guidance for 2026
But the fundamentals are solid: irreplaceable brands, demonstrated pricing power, and cocoa costs are already normalizing.
Analyst Analysis
| Metric | Value |
|---|---|
| Consensus | Buy |
| Analysts | 22 |
| Average Target | $68 |
| Target Range | $62 - $84 |
| Upside | +19.2% |
Main Risks
- Cocoa/sugar costs — Big price swings in commodities squeeze margins
- Currency exposure — 75% revenue outside the US, strong dollar hurts
- Food regulation — Labeling, restrictions on ultra-processed foods
- Local competition — Regional brands gaining share in emerging markets
- Changing habits — Trend towards 'healthy' snacks
Current Valuation
| Metric | Value |
|---|---|
| Price | $57.03 |
| P/E Forward | 16.9x (vs historical ~22x) |
| Div Yield | 3.5% |
| 52-Week High | $71.15 |
| Current Drawdown | -20% from high |
Conclusion
MDLZ at $57 is an opportunity to buy the owner of Oreo, Cadbury, and Milka at a price vs. profit of 16.9x — a significant discount compared to its historical average of ~22x. The 3.5% dividend is attractive and well-covered (payout 55%). The cocoa scare created the opportunity, but the fundamentals (irreplaceable brands, global presence, pricing power) haven't changed. With 19% upside according to analysts plus the dividend, the total expected return is ~23%.
Research date: Apr 2, 2026 | Next review: Oct 2026
This is not financial advice.
Update August 26, 2026 — Repurchase (Position #151)
Entry price: $62.99 (open) | P/E TTM 23.1x | P/E forward 18.8x | Dividend 3.3% | Market cap $81.1 billion. First purchase: #29 on April 2, 2026 at $57.03 (+10.5% since then).
Second quarter 2026 (July 28). Sales $9,355 million (+4.1%; consensus $9,227 million); organic growth +2.2% (price +1.5 pp, volume/mix +0.7 pp); reported earnings per share $1.20 (+144.9%); adjusted earnings $0.73 (−2.7% at constant currency; consensus $0.67). By region (organic): Latin America +8.4%, AMEA +7.1%, North America +3.4%, Europe −3.5%. Adjusted gross margin 34% (+20 bp); adjusted operating margin 13.1% (−120 bp, on inputs and more advertising investment). First half: sales $19,435 million (+6.2%), adjusted earnings $1.40 (−4.8%), free cash flow $700 million, $1.5 billion returned to shareholders.
2026 guidance (raised). Organic growth 'of at least 2%' (previously 0–2%); adjusted earnings per share flat to +5% at constant currency; free cash flow ~$3 billion; currency adds ~2 pp to sales and $0.05 to earnings.
Cocoa. Peak ~$12,487/t on December 19, 2024; low $2,863 on March 2, 2026; rebound to $6,520 on July 9 (floods in Ivory Coast and Ghana), ~$5,700 in mid-July. Management: hedges were locked at elevated prices early in the year, so costs do not yet reflect spot; 2026 input inflation 'low single-digit' as a share of cost of sales; recent spikes are 'technical factors' (short squeezes), not a supply deficit; '2027 is protected from cocoa volatility' via productivity, AI savings and less cocoa-intensive products. Full year 2025: sales $38.54 billion (+5.8%), organic +4.3% (price +8%, volume −3.7%), adjusted earnings $2.92 (−12.8%), gross margin 28.4% vs 39.1%, free cash flow $3.2 billion, $4.9 billion returned.
Dividend. Raised 4% to $0.52 a quarter (July 28; record September 30, payable October 14, 2026); $2.08 a year; payout ~73% of reported earnings. Buyback authorized: $9 billion (2025–2027).
Other 2026. CFO Amit Banati since July 1 (Luca Zaramella to COO); new Toblerone line in Bern (CHF 65 million, March); Bernstein (August 23) sees a merger with Hershey as unlikely. Buy consensus, 24 analysts, average target $69.13; 52-week range $51.20–$66.65.
Current risks. Cocoa and hedge lag; weak consumer and store brands at a record; Europe negative; GLP-1 (up to −1.5% volume by 2035 per the company); debt $21.2 billion; tariffs, Middle East and currency.
Update August 31, 2026 — Third buy (Position #153)
Entry price: $62.24 (open) | P/E TTM 22.8x | P/E forward 18.5x | Dividend 3.3% | Market cap $79.8 billion. Previous buys: #29 (April 2, $57.03) and #151 (August 26, $62.99). The third entry comes −1.2% vs the second.
What's new since August 26. Cocoa moved against us: ICE New York jumped ~5.1% on August 28 to ~$6,488/ton (touching $6,500 intraday) — +25% in the month and ~+14% vs mid-July's ~$5,700. Causes: StoneX cut its 2026/27 global surplus forecast from 149,000 to ~25,000 tonnes; Ghana's COCOBOD sees the 2026/27 crop possibly at 450,000–550,000 tonnes (vs ~750,000); Ivory Coast estimates ~1.8 million tonnes (~−18%); black pod disease spreading; and record fund short-covering. Context: it still sits ~48% below the December 2024 peak ($12,487) and far above the March 2026 low ($2,863). The company's stance (July 28) hasn't changed: 2026 hedges locked, input inflation 'low single-digit', and '2027 protected from cocoa volatility'.
Nothing else new: zero analyst moves from August 27–31 (Moderate Buy consensus, target ~$67–69); the only corporate agenda item is the COO and CFO fireside at Barclays' consumer conference on September 9. The $0.52 quarterly dividend has a September 30 record date and October 14 payment.
This is not financial advice. Consult a certified financial advisor.
The author may hold positions in the securities discussed.
Past performance does not guarantee future results.